Lotus Pharmaceutical Co., Ltd. (1795.TW) TAI

284.50

-6.5(-2.23%)

Updated at October 23 02:38PM

Currency In TWD

Valuation

Market Cap70.57B
Enterprise Value78.2B
P/E Ratio15.17
PEG Ratio-1.38
Price/Sales Ratio3.91
Price/Book Ratio3.62
Enterprise/Revenue4.31
Enterprise/EBITDA10.43

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.25
Operating Margin0.33

Management Effectiveness

Return On Assets0.13
Return On Equity0.23

Income Statement

Revenue18.58B
Revenue/Share73.77
Gross Profit10.92B
EBITDA8.21B
Net Income5.07B
Diluted EPS19.26

Balance Sheet

Total Cash4.11B
Total Cash/Share15.87
Total Debt11.62B
Total Debt/Equity0.57
Current Ratio1.55
Book Value Per Share78.58

Price History

52-Week Change9.42
52-Week High319.5
52-Week Low172.5
Moving Average 50 Days222.64
Moving Average 200 Days233.42

Statistics

Average Volume2.98M
Shares Outstanding262.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate5.78
Trailing Annual Dividend Yield2.03
Payout Ratio0.25
Last Split Factor53:50
Last Split DateSeptember 08, 2010